Golden State Wealth Management’s Boston Scientific BSX Stock Holding History

Golden State Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.3K	Sell	382 -271	-42%	-$14.7K	﹤0.01%	993
2026 Q1	$41K	Hold	653	–	–	﹤0.01%	732
2025 Q4	$62.3K	Hold	653	–	–	0.01%	635
2025 Q3	$63.8K	Hold	653	–	–	0.01%	614
2025 Q2	$70.1K	Hold	653	–	–	0.01%	570
2025 Q1	$65.9K	Sell	653 -569	-47%	-$57.3K	0.01%	532
2024 Q4	$109K	Buy	+1,222	New	+$108K	0.02%	415
2020 Q2	–	Sell	-336	Closed	-$11K	–	284
2020 Q1	$11K	Buy	+336	New	+$13.1K	﹤0.01%	599
2019 Q4	–	Sell	-136	Closed	-$6K	–	166
2019 Q3	$6K	Buy	136 +100	+278%	+$4.24K	﹤0.01%	823
2019 Q2	$1K	Sell	36 -447	-93%	-$17.2K	﹤0.01%	1015
2019 Q1	$19K	Buy	+483	New	+$18.4K	0.01%	636

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Golden State Wealth Management's BSX Position: Q2 2026 in Review

Golden State Wealth Management reduced its Boston Scientific (BSX) stake by 42% in Q2 2026, selling an estimated $14.7K and leaving 382 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Golden State Wealth Management first reported a position in BSX in Q1 2019 and has held it in 11 quarters since. The position peaked at $109K in Q4 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Golden State Wealth Management held 382 shares of Boston Scientific worth $16.3K as of Q2 2026.
Golden State Wealth Management sold 271 Boston Scientific shares in Q2 2026, an estimated $14.7K.
Boston Scientific made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #993 holding.
Golden State Wealth Management first reported a position in Boston Scientific in Q1 2019 and has held it in 11 quarters since.
Golden State Wealth Management's Boston Scientific position peaked at $109K in Q4 2024.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.